Skip to the content
Search
Beyond Type 1
Menu
BEYOND TYPE 1
Show sub menu
About
Board of Directors
The Team
Leadership Council
Portfolio
Press
Careers
Contact
Join Us
Diabetes
Type 1 Info
Type 2 Info
Diabetes Management
Newly Diagnosed
Forms Of Diabetes
Autoimmune Diseases
Pregnancy with Type 1 Diabetes
Research
Resources
Stories
Diabetes News
Diabetes Management
Diabetes + Exercise
Mental Health + Diabetes
Food and Diabetes
School Resources
Sex, Drugs + Rock & Roll
Travel + Adventure
Previously Healthy
GetInsulin.org
Newsletter
Programs
Beyond Type 1 App
Beyond Barriers
Beyond Scholars
Community Table
GetInsulin.org
Marathon Team
Snail Mail Club
TuDiabetes
Type 1 Signs
Jesse Was Here
Advocacy
Donate
Search
Tag:
Cure
Vertex VX-880 Clinical Results Lead To Insulin-Independence
Here's what you need to know about Vertex's recent results from their stem-cell therapy for type 1 diabetes.
Explaining the Research: What Will It Take to Cure Diabetes?
JDRF Chief Scientific Officer Sanjoy Dutta explains what goes into finding cures and what makes type 1 diabetes research uniquely challenging.
Vertex Acquires ViaCyte, Combining Resources Toward a T1D Cure
The global biotech giant is set to acquire ViaCyte for $320 million.
New Documentary: ‘The Human Trial’ is a Quest to Cure Type 1 Diabetes
The film pulls the curtain back on one biotech company working to find a functional cure for type 1 diabetes.
Stem Cell Therapy for Type 1 Diabetes: Patient Achieved Insulin Independence on Day 270
A patient in the Vertex Pharmaceutical’s clinical trial using stem-cell therapy to treat type 1 diabetes has achieved insulin independence on Day 270 of the trial.
Stem-Cell Therapy for Type 1 Diabetes Reduced Patient’s Insulin Needs by 91%
The early results of a clinical trial using stem-cell therapy to treat type 1 diabetes reduced the patient’s insulin needs by 91%.
JDRF Announces New Center of Excellence to Advance T1D Research
On February 23, 2021, JDRF announced the launch of the JDRF Center of Excellence in collaboration with the Harvard Stem Cell Institute in New England.
Implanted PEC-01 Cells Capable of Producing Insulin According to New Data Presented from ViaCyte
ViaCyte presented preliminary data from their PEC-Direct trial, showing that PEC-01 cells are capable of producing insulin in patients with type 1 diabetes.
Research for Better Management + Cure of Type 1 diabetes
Research to cure and treat Type 1 mostly fits into five areas: 1) beta cell health and regeneration, 2) immunotherapy, 3) replacement beta cells, 4) device/technology innovation and 5) medications for...
Tortoise vs the Hare – Islet Transplantation vs Technology
The race to find a more effective and non-evasive, injection-free therapy for patients with Type 1 diabetes involves many players. The remaining question is not when, but who is going to win: the tort...
Why Support Diabetes Research?
In order to be successful, in order to change and save lives, diabetes research requires funding. When someone supports an organization that funds research, they become a part of positive change.